Ruhi Ahmad Khan - 15 Nov 2021 Form 4 Insider Report for Caribou Biosciences, Inc. (CRBU)

Role
Chief Business Officer
Signature
/s/ Barbara G. McClung, attorney-in-fact
Issuer symbol
CRBU
Transactions as of
15 Nov 2021
Net transactions value
$0
Form type
4
Filing time
16 Nov 2021, 17:58:14 UTC
Previous filing
08 Nov 2021
Next filing
24 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRBU Option to purchase Common Stock Award $0 +225,000 $0.000000 225,000 15 Nov 2021 Common Stock 225,000 $21.73 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option shall vest on November 8, 2022, and the remaining shares subject to the option shall vest monthly thereafter (1/48 of the shares per month for the 36 months following the one-year cliff), subject to the reporting person's continued service to the Issuer through the applicable vesting dates.